In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...

The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the ...

In the fourth part of this roundtable discussion, a panel of subject matter experts dive into data exchange challenges relating to the Drug Supply Chain Security Act.

Pharma prepares for looming tariffs, as the US president signals a phased increase starting Aug. 1, but the official starting ...

Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.

Per the deal, Thermo Fisher will acquire Sanofi’s sterile drug product manufacturing facility in Ridgefield, NJ, to support production of Sanofi therapies and expand capacity for US-based pharma and ...

In the second part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, explains how the private sector should strategically support and scale ...

The buzz around GLP-1 agonists like Ozempic and Wegovy is undeniable, fueled by social media virality and impressive clinical results. This has driven a staggering surge in prescriptions, with some ...

In the third part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...

In an interview with Pharmaceutical Executive, Corina Dutcus, SVP at Eisai, discussed nearly five-year follow-up data from the LEAP-002 study, which—despite missing its primary endpoint—reinforced ...

In the first part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...